Discover 884 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinsonās disease. The cityās growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 884
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: Englewood CO, Albuquerque NM, West Jordan UT,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea
for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: Englewood CO, Albuquerque NM, West Jordan UT, Omaha NE,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Diabetic Nerve Pain Study of a Non-Opioid Medication for Adults With Ongoing Foot and Leg Pain
Location: Englewood CO, West Jordan UT, Norfolk NE, Lincoln NE,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
for
Metastatic Colorectal Cancer
Location: Aurora CO, Lone Tree CO, Phoenix AZ, Denton TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT04929223
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
FeaturedActive & Responsive
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
for
Muscular Atrophy, Spinal
Location: Aurora CO, Dallas TX, Little Rock AR, Madera CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 2
Code: NCT05861999
Phase 4, Recruiting
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Fort Collins CO, Albuquerque NM, Peoria AZ, Frisco TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06972446
Phase 2, Recruiting
Featured
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
for
Multiple Myeloma
Location: Denver CO, Scottsdale AZ, Minneapolis MN, Rochester MN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07095452
Phase 2, Phase 3, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Location: Aurora CO, Oklahoma City OK, Minneapolis MN, Austin TX,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07024784
Phase 2, Recruiting
Featured
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
for
Neoplasms
Location: Aurora CO, San Antonio TX, Duarte CA, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06884618
Phase 1, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Aurora CO, Lincoln NE, Chandler AZ, Palestine TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase 2, Phase 3, Recruiting
Featured
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: Aurora CO, Salt Lake City UT, Tucson AZ, Dallas TX,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase 1, Phase 2, Recruiting
Featured
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
for
Non Small Cell Lung Carcinoma, c-MET
Location: Aurora CO, Lone Tree CO, Salt Lake City UT, Lubbock TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06772623
Phase 1, Phase 2, Recruiting
Featured
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
for
Muscular Atrophy, Spinal
Location: Aurora CO, Fort Worth TX, Dallas TX, Little Rock AR,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 2
Code: NCT05861986
Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Aurora CO, Salt Lake City UT, Bountiful UT, Wichita KS,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Featured
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
for
Hemophilia A
Location: Aurora CO, Minneapolis MN, Iowa City IA, San Antonio TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416604
Phase 3, Recruiting
Featured
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema